Dáil Éireann Debate, Tuesday - 3 October 2017
308. Deputy Jack Chambers asked the Minister for Health if the drug prembrolizumab will be licensed for use in the treatment of fine cell neuroendocrine rectal cancer; and if he will make a statement on the matter. [41316/17]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
